HSC treatments are standard-of-care for multiple sclerosis treatments, and it has additionally been successfully used to treat cancers like leukemia and metabolic, immune, and blood disorders, such as Krabbe disease and sickle cell disease. Over 1300 clinical trials are currently being conducted to examine how it can treat neurological conditions as well - including cerebral palsy and Autism.
